Still, if the COAD and rectal cancers are pooled together into CRC, the correlation should be even more highly significant.
← all excerpts
Characterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancer.
1
—
—
Still, if the COAD and rectal cancers are pooled together into CRC, the correlation should be even more highly significant.